Cardiovascular Systems Inc Annual Meeting of Stockholders
November 16, 2016

Corporate Profile

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital... More >>

Recent News

More >>
Cardiovascular Systems to Webcast Fiscal 2017 First-Quarter Earnings Conference Call Wednesday, October 26 10/05/16
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2017 first-quarter conference call on Wednesday, October 26, 2016, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company’s results for its fiscal first quarter ended September 30, 2016, and its financial outlook. The company will issue a post-market earnings release prior to the call on October 26. To access the live webcast, go to the events section of the company’s investor relations website, , on the day of the conference call and click on the webcast link. A webcast replay will be available beginning at 6:45 p.m. CT the same day. To participate in the conference call, dial (877) 201-0168 and enter 93470708. Please dial in at least 10 minutes prior to the call. If you do not have access to the...
More >>
Cardiovascular Systems Launches the Take A Stand Against Amputation Program in Time for September Peripheral Artery Disease (PAD) Awareness Month 09/01/16
September marks Peripheral Artery Disease (PAD) Awareness Month. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), has launched a public awareness and patient advocacy program, Take A Stand Against Amputation, to provide education about the disease and treatment options. Up to a staggering 18 million Americans1 suffer from this potentially life-threatening disease. According to the American Heart Association, PAD patients have a six to seven times greater risk of coronary artery disease, heart attack and stroke than the rest of the population. If left untreated, those who suffer from PAD are at risk of serious consequences. In fact, each year 160,000 to 180,000 Americans undergo amputation of a limb as a result of complications associated with peripheral artery disease (PAD)2. Of those suffering from PAD, up to 3.5 million have progressed to critical limb ischemia (CLI) 3 , the most severe and potentially deadly form of PAD, where the blood vessels become dangerously narrow, leading...
More >>